X

WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT

•

M

E

N

U

•

January 18, 2018

Paul Lammers, M.D., M.Sc. Joins Triumvira as President and Chief Executive Officer

Read the full press release here.

RELATED NEWS

Satellos Announces Closing of US$40M Public Offering Titan Announces the Closing of Conavi’s Private Placement of Subscription Receipts and Provides Update on the Transaction Roberto Bellini Receives the 2024 Bloom Burton Award Acquisition of Fusion Pharmaceuticals Completed Three Finalists Announced for the 2024 Bloom Burton Award Apotex to Acquire Searchlight Pharma, a Canadian Specialty Branded Pharmaceutical Leader Cybin Announces Closing of the Oversubscribed Private Placement of U.S. $150 Million The Globe and Mail | Vancouver readies for its position as a global pharma capital as B.C.’s biotech boom takes off Registration for BBHIC2024 Now Open! Bloom Burton & Co. Announces the 2024 Bloom Burton Award

2025 BLOOM BURTON & CO DESIGNED & DEVELOPED BY THE TEAM AT PIXELCARVE MEMBER CIRO MEMBER CIPF PRIVACY POLICY COMPLAINT BEST EXECUTION POLICY ACCESSIBILITY POLICY BUSINESS CONTINUITY PLAN LEGAL DISCLAIMER CONFLICTS OF INTEREST